Partner With Us NRI
Nestle India Ltd>
  • CMP : 2,467.8 Chg : -6.40 (-0.26%)
  • Target : 23,000.0 (11.33%)
  • Target Period : 12-18 Month

25 Apr 2023

Robust growth across categories...

About The Stock

Nestlé India (NIL) is the largest food company in India with over ₹ 16000 crore of sales. It is broadly present in infant & baby food products, noodles, chocolates & beverage categories. In the last five years, the company has forayed into newer categories and launched more than 110 new products.

  • The company has nine manufacturing facilities including newly commissioned plant in Sanand, Gujarat. Its major brands include Maggi, Nescafe, KitKat, Cerelac among others
Q1CY23 Results

Nestlé India reported robust growth across segments

  • Sales were up 21.3% YoY led by mix of volume & pricing growth
  • EBITDA was at ₹ 1095.5 crore, up 18.5% YoY with margins at 22.8%
  • Adjusted PAT was at ₹ 736.6 crore (up 23.9% YoY)
What should Investors do?

Nestlé India’s share price has given return of 128% in the last five years (from ₹ 9062 in April 2018 to ₹ 20665 in April 2023).

  • We remain positive on growth prospects factoring in 10.6% revenue cagr along with 260 bps operating margin expansion in next two years
  • We continue to maintain our HOLD rating on the stock
Target Price and Valuation

We value the stock at ₹ 23000, valuing the business 65x CY24 earnings

Key Triggers for future price performance
  • The company is undertaking a capex of ₹ 5000 crore in the next three years to expand the capacity of its existing products. Many of its plant’s capacity utilisation has reached their peak
  • NIL is increasing its rural footprint from 80,000 villages to 1.2 lakh villages in the next two years. We believe distribution expansion in rural India (contributes 20% to sales) is driving growth in core categories
  • Palm Oil, Crude & Wheat prices have declined significantly from their peak. Milk & coffee prices have remained elevated & would continue to remain firm in CY23. However, we believe gross margin would bottom out in CY23. We expect 260 bps gross margin expansion in next two years
Alternate Stock Idea

We like Tata Consumer Products in our FMCG coverage.

Strong innovation & premiumisation strategy in salt and tea is expected to drive margins in these established categories. Newer categories like pulses, spices and dry fruits to drive volume growth given large opportunity size We value the stock at ₹ 950 on ascribing 52x FY25 earnings multiple

Key Financial Summary

Key Financials CY19 CY20 CY21 CY22 5 Year CAGR (CY17-CY22) CY23E CY24E CAGR (CY22-24E)
Net Sales 12,295.3 13,290.2 14,633.7 16,789.5 0.1 18,955.6 20,945.3 0.1
EBITDA 2,864.3 3,201.5 3,591.5 3,712.6 0.1 4,355.0 5,171.7 0.2
EBITDA Margin % 23.3 24.1 24.5 22.1 - 23.0 24.7 -
Adjusted Net Profit 1,969.6 2,082.4 2,320.8 2,390.5 0.1 2,891.3 3,400.8 0.2
Adjusted EPS (|) 204.3 216.0 240.7 247.9 0.1 299.9 352.7 0.2
P/E 101.1 95.7 92.9 83.3 - 68.9 58.6 -
RoNW % 101.9 103.1 104.1 87.0 - 84.5 86.5 -
RoCE (%) 56.9 54.6 57.3 54.4 - 57.0 61.6 -
- - - - - - - - -
Source: Company, ICICI Direct Research

Key takeaways of recent quarter

Q1CY23 Results:  Milk prices continues to hurt margins; Softening of other commodities ease pressure

  • NIL witnessed a growth of 21.3% to |4830.5 crore led by mix of volume & pricing growth. Domestic sales grew by 21.2% & exports were up by 24.9%. The company witnessed strong growth across categories. It is driving growth in export market through mainstream & ethnic channels  


  • Prepared dishes segment (noodles, cooking aids) continues to witness strong growth led by media campaigns. NIL is witnessing portfolio upgradation (we believe larger pack getting traction) in this category. Chocolates category growing at robust pace continuing the growth momentum         of last two years. KITKAT & MUNCH saw strong growth led by media campaign & consumer engagement.


  • Beverage segment witnessed a healthy growth through market share gains in Nescafe classic, Nescafe sunrise & Nescafe Gold. We believe high raw material prices also led to pricing growth in this category


  • Milk product category registered double digit growth during the quarter led by strong growth in MILKMAID. We believe elevated milk prices supported pricing growth in this category.


  • E-commerce channel is witnessing a strong growth with rapid growth in quick commerce. The company is continuing its distribution expansion in rural India with target of 1.2 lakh village expansion. The company also saw strong growth in Out of Home channel across brands


  • Gross margin contracted by 159 bps mainly due to higher milk prices. Though, decline in palm oil & wheat prices benefited the company during the quarter, milk remain the largest raw material for the company. Moreover, green coffee prices also remain at an elevated level. Employee & overhead spends (% of sales) were down by 56 bps & 64 bps respectively.


  • Operating profit grew by 18.5% to |1095.5. Operating margin contracted by 62 bps to 22.8%. Net profit grew by 23.9% to |736.6 crore led by higher operating profit, other income & lower taxation. The company has announced interim dividend of | 27/ share (on 12th April 2023).

  • The company launched new product ‘ThickenUp Clear’, a food and beverage thickener from our Nestlé Health Science portfolio. ThickenUp Clear can be used to help patients with swallowing difficulties especially in oropharyngeal dysphagia. Newly launched products ‘GERBER’ cereals & ‘CEREGROW’ grain selection also performing well for the company. In Pet Food category, the company launched new product in cat food portfolio.



ICICI Direct endeavours to provide objective opinions and recommendations. ICICI Direct assigns ratings to its stocks according -to their notional target price vs. current market price and then categorizes them as Buy, Hold, Reduce and Sell. The performance horizon is two years unless specified and the notional target price is defined as the analysts valuation for a stock


Buy: >15%

Hold: -5% to 15%;

Reduce: -15% to -5%;

Sell: <-15%




Pankaj Pandey

Head – Research




ICICI Direct Research Desk,

ICICI Securities Limited,

Third floor, Brillanto House,

Road No 13, MIDC,

Andheri (East)

Mumbai – 400 093








I/We, Sanjay Manyal, MBA (Finance) Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. It is also confirmed that above mentioned Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months and do not serve as an officer, director or employee of the companies mentioned in the report.

Terms & conditions and other disclosures:

ICICI Securities Limited (ICICI Securities) is a full-service, integrated investment banking and is, inter alia, engaged in the business of stock brokering and distribution of financial products.

ICICI Securities is Sebi registered stock broker, merchant banker, investment adviser, portfolio manager and Research Analyst. ICICI Securities is registered with Insurance Regulatory Development Authority of India Limited (IRDAI) as a composite corporate agent and with PFRDA as a Point of Presence. ICICI Securities Limited Research Analyst SEBI Registration Number – INH000000990. ICICI Securities Limited SEBI Registration is INZ000183631 for stock broker. Registered Office Address: ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025. CIN: L67120MH1995PLC086241, Tel: (91 22) 6807 7100. ICICI Securities is a subsidiary of ICICI Bank which is India’s largest private sector bank and has its various subsidiaries engaged in businesses of housing finance, asset management, life insurance, general insurance, venture capital fund management, etc. (“associates”), the details in respect of which are available on www.icicibank.com.


Investments in securities market are subject to market risks. Read all the related documents carefully before investing.


Registration granted by Sebi and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. None of the research recommendations promise or guarantee any assured, minimum or risk-free return to the investors.


Name of the Compliance officer (Research Analyst): Mr. Anoop Goyal

Contact number: 022-40701000 E-mail Address: complianceofficer@icicisecurities.com


For any queries or grievances: Mr. Prabodh Avadhoot Email address: headservicequality@icicidirect.com Contact Number: 18601231122


ICICI Securities is one of the leading merchant bankers/ underwriters of securities and participate in virtually all securities trading markets in India. We and our associates might have investment banking and other business relationship with a significant percentage of companies covered by our Investment Research Department. ICICI Securities and its analysts, persons reporting to analysts and their relatives are generally prohibited from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover.


Recommendation in reports based on technical and derivative analysis centre on studying charts of a stocks price movement, outstanding positions, trading volume etc as opposed to focusing on a companys fundamentals and, as such, may not match with the recommendation in fundamental reports. Investors may visit icicidirect.com to view the Fundamental and Technical Research Reports.


Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein.


ICICI Securities Limited has two independent equity research groups: Institutional Research and Retail Research. This report has been prepared by the Retail Research. The views and opinions expressed in this document may or may not match or may be contrary with the views, estimates, rating, and target price of the Institutional Research.


The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would endeavour to update the information herein on a reasonable basis, ICICI Securities is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent ICICI Securities from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or ICICI Securities policies, in circumstances where ICICI Securities might be acting in an advisory capacity to this company, or in certain other circumstances.


This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ICICI Securities will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. ICICI Securities accepts no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice.


ICICI Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months.


ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction.


ICICI Securities or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the companies mentioned in the report in the past twelve months.



ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its associates or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ICICI Securities nor Research Analysts and their relatives have any material conflict of interest at the time of publication of this report.


Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions.


ICICI Securities or its subsidiaries collectively or Research Analysts or their relatives do not own 1% or more of the equity securities of the Company mentioned in the report as of the last day of the month preceding the publication of the research report.


Since associates of ICICI Securities and ICICI Securities as a entity are engaged in various financial service businesses, they might have financial interests or actual/ beneficial ownership of one percent or more or other material conflict of interest various companies including the subject company/companies mentioned in this report.


ICICI Securities may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.


Neither the Research Analysts nor ICICI Securities have been engaged in market making activity for the companies mentioned in the report.


We submit that no material disciplinary action has been taken on ICICI Securities by any Regulatory Authority impacting Equity Research Analysis activities.


This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ICICI Securities and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.





























Read More